FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200078165> ?p ?o ?g. }

• W4200078165 endingPage "39" @default.
• W4200078165 startingPage "31" @default.
• W4200078165 abstract "Objectives: This study aims to investigate clinical presentations, antiphospholipid antibody patterns and their levels, therapeutic regimens, and outcomes in patients with antiphospholipid syndrome (APS) admitted to a tertiary care hospital of a South Asian country. Patients and methods: Between January 2009 and December 2019, a total of 216 patients with APS (8 males, 208 females; median age: 35.7±6.9 years; range, 20 to 76 years) who either fulfilled the modified Sydney criteria or those who satisfied only clinical criteria along with positive antiphospholipid antibody on at least one occasion (probable APS) were retrospectively analyzed. Results: The majority of the patients (n=183, 84.7%) had obstetric complications, followed by venous thrombosis in 23 (10.8%) patients. Recurrent early abortions in 126 (58.6%) and deep venous thrombosis in 16 (7.4%) patients were the most prevalent obstetrical and venous events, respectively, whereas limb gangrene in seven (3.3%) and ischemic stroke in seven (3.3%) were the most common arterial events. A total of 190 (88%) patients had primary APS, while 26 (12%) had secondary APS. Systemic lupus erythematosus was the frequent association with secondary APS found in 19 (73%) patients. Immunoglobulin M (IgM) anticardiolipin antibody was present in 173 (65.0%) patients, being the most commonly reported antibody. Probable catastrophic APS was found in four (1.9%) patients. Majority of the patients (n=190, 87.9%) were treated with a combination of acetylsalicylic acid and low-molecular-weight heparin. Single mortality was observed in our study population due to complications related to catastrophic APS. Conclusion: Antiphospholipid syndrome has a wide range of thrombotic and obstetrical manifestations with important variations in different regions of the world. There is a significant morbidity and mortality related to APS, despite treatment with anticoagulation and; therefore, describing prognostic markers and optimal therapeutic interventions is pivotal to prevent complications." @default.
• W4200078165 created "2021-12-31" @default.
• W4200078165 creator A5007052326 @default.
• W4200078165 creator A5037347807 @default.
• W4200078165 creator A5046664211 @default.
• W4200078165 creator A5054727940 @default.
• W4200078165 creator A5086146588 @default.
• W4200078165 creator A5090565042 @default.
• W4200078165 date "2021-10-18" @default.
• W4200078165 modified "2023-10-18" @default.
• W4200078165 title "A retrospective review of antiphospholipid syndrome from a South Asian country" @default.
• W4200078165 cites W115642794 @default.
• W4200078165 cites W1596313173 @default.
• W4200078165 cites W1851052710 @default.
• W4200078165 cites W1975074770 @default.
• W4200078165 cites W1976003645 @default.
• W4200078165 cites W2003743657 @default.
• W4200078165 cites W2042958596 @default.
• W4200078165 cites W2044043417 @default.
• W4200078165 cites W2054330426 @default.
• W4200078165 cites W2068651023 @default.
• W4200078165 cites W2069797332 @default.
• W4200078165 cites W2120492526 @default.
• W4200078165 cites W2150541748 @default.
• W4200078165 cites W2487482563 @default.
• W4200078165 cites W2514539105 @default.
• W4200078165 cites W2536216511 @default.
• W4200078165 cites W2538345017 @default.
• W4200078165 cites W2574962995 @default.
• W4200078165 cites W2580867287 @default.
• W4200078165 cites W2592754561 @default.
• W4200078165 cites W2596440192 @default.
• W4200078165 cites W2621312629 @default.
• W4200078165 cites W2752830593 @default.
• W4200078165 cites W2765633152 @default.
• W4200078165 cites W2791088123 @default.
• W4200078165 cites W2938707131 @default.
• W4200078165 cites W2970428872 @default.
• W4200078165 cites W2977655792 @default.
• W4200078165 cites W2980608542 @default.
• W4200078165 cites W3025949130 @default.
• W4200078165 cites W4211023937 @default.
• W4200078165 cites W4211151340 @default.
• W4200078165 cites W4235766586 @default.
• W4200078165 cites W4239160933 @default.
• W4200078165 doi "https://doi.org/10.46497/archrheumatol.2022.8979" @default.
• W4200078165 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35949874" @default.
• W4200078165 hasPublicationYear "2021" @default.
• W4200078165 type Work @default.
• W4200078165 citedByCount "1" @default.
• W4200078165 countsByYear W42000781652023 @default.
• W4200078165 crossrefType "journal-article" @default.
• W4200078165 hasAuthorship W4200078165A5007052326 @default.
• W4200078165 hasAuthorship W4200078165A5037347807 @default.
• W4200078165 hasAuthorship W4200078165A5046664211 @default.
• W4200078165 hasAuthorship W4200078165A5054727940 @default.
• W4200078165 hasAuthorship W4200078165A5086146588 @default.
• W4200078165 hasAuthorship W4200078165A5090565042 @default.
• W4200078165 hasBestOaLocation W42000781651 @default.
• W4200078165 hasConcept C126322002 @default.
• W4200078165 hasConcept C127413603 @default.
• W4200078165 hasConcept C141071460 @default.
• W4200078165 hasConcept C167135981 @default.
• W4200078165 hasConcept C187212893 @default.
• W4200078165 hasConcept C2776626339 @default.
• W4200078165 hasConcept C2776874634 @default.
• W4200078165 hasConcept C2776884760 @default.
• W4200078165 hasConcept C2777247642 @default.
• W4200078165 hasConcept C2780011451 @default.
• W4200078165 hasConcept C2780645631 @default.
• W4200078165 hasConcept C2780868729 @default.
• W4200078165 hasConcept C2908647359 @default.
• W4200078165 hasConcept C71924100 @default.
• W4200078165 hasConcept C78519656 @default.
• W4200078165 hasConcept C99454951 @default.
• W4200078165 hasConceptScore W4200078165C126322002 @default.
• W4200078165 hasConceptScore W4200078165C127413603 @default.
• W4200078165 hasConceptScore W4200078165C141071460 @default.
• W4200078165 hasConceptScore W4200078165C167135981 @default.
• W4200078165 hasConceptScore W4200078165C187212893 @default.
• W4200078165 hasConceptScore W4200078165C2776626339 @default.
• W4200078165 hasConceptScore W4200078165C2776874634 @default.
• W4200078165 hasConceptScore W4200078165C2776884760 @default.
• W4200078165 hasConceptScore W4200078165C2777247642 @default.
• W4200078165 hasConceptScore W4200078165C2780011451 @default.
• W4200078165 hasConceptScore W4200078165C2780645631 @default.
• W4200078165 hasConceptScore W4200078165C2780868729 @default.
• W4200078165 hasConceptScore W4200078165C2908647359 @default.
• W4200078165 hasConceptScore W4200078165C71924100 @default.
• W4200078165 hasConceptScore W4200078165C78519656 @default.
• W4200078165 hasConceptScore W4200078165C99454951 @default.
• W4200078165 hasIssue "1" @default.
• W4200078165 hasLocation W42000781651 @default.
• W4200078165 hasLocation W42000781652 @default.
• W4200078165 hasLocation W42000781653 @default.
• W4200078165 hasOpenAccess W4200078165 @default.
• W4200078165 hasPrimaryLocation W42000781651 @default.
• W4200078165 hasRelatedWork W2025911670 @default.

• next